BioCentury
ARTICLE | Clinical News

Allob: Additional Phase IIa data

October 24, 2016 7:00 AM UTC

Additional data from 8 patients with symptomatic degenerative lumbar disc disease that required interbody fusion in an open-label, Belgian Phase IIa trial showed that a single implantation of Allob mi...